Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Effects of Gaze Stabilization Exercises and Optokinetic Training in Peripheral Vestibular Disorders

3 juli 2026 uppdaterad av: Foundation University Islamabad
This study compares the effectiveness of Gaze Stabilization Exercises and Optokinetic Training in improving dizziness, balance, and confidence in individuals with peripheral vestibular disorders.

Studieöversikt

Detaljerad beskrivning

Peripheral vestibular disorders (PVD) commonly cause dizziness, postural instability, and decreased balance confidence, which increase the risk of falls and limit participation in daily activities. Vestibular rehabilitation is widely used to manage these symptoms. Among rehabilitation approaches, Gaze Stabilization Exercises (GSE) aim to improve vestibulo-ocular reflex function, while Optokinetic Training (OKT) promotes symptom habituation through visual motion stimulation. However, the comparative effectiveness of these two interventions remains unclear.

This study aims to compare the effects of GSE and OKT on dizziness severity, postural stability, and balance confidence in individuals with peripheral vestibular disorders. Participants will undergo intervention sessions three times per week for six weeks. Outcome measures will be assessed at baseline, mid-intervention (week 3), and post-intervention (week 6).

Primary and secondary outcomes will include the Dizziness Handicap Inventory (DHI), Dynamic Gait Index (DGI), and the Activities-specific Balance Confidence (ABC) Scale. Data will be analyzed using SPSS statistical software. It is hypothesized that both interventions will improve dizziness, balance, and confidence, though differences in effectiveness may exist between the two approaches.

The findings of this study are expected to contribute to evidence-based vestibular rehabilitation by identifying effective intervention strategies. The results may help clinicians design personalized rehabilitation programs aimed at reducing fall risk, improving functional mobility, and enhancing quality of life in individuals with peripheral vestibular disorders.

Studietyp

Interventionell

Inskrivning (Faktisk)

32

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Islamabad, Pakistan, 44000
        • Foundation University College of Physical Therapy

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Nej

Beskrivning

Inclusion Criteria:

  • Male and female patients aged 35-55 years
  • Complaining of dizziness for at least three months
  • Reporting at least one dizziness episode per month
  • Medical diagnosis of chronic peripheral vestibular disease
  • Willingness to participate and provide informed consent

Exclusion Criteria:

  • Medical history or signs of central nervous system disorders and/or psychiatric disorders
  • Uncontrolled hypertension and diabetes
  • Incapacity to understand and follow simple verbal commands
  • Inability to independently remain in standing position
  • Severe visual impairment or visual impairment not compensated by corrective lenses
  • Orthopedic disorders resulting in movement limitation or use of lower-limb prostheses
  • Previous body balance rehabilitation in the last six months

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Gaze Stabilization Exercises

Purpose:

Enhance gaze stability, postural control, and confidence in functional activities.

Description:

Week 1: Sitting, VOR x1 horizontal, fixate on near target - start gaze stability.

Week 2: Sitting, VOR x1 vertical, near/far target - increase head speed. Week 3: Standing, VOR x1 horizontal, fixate on target - improve upright balance.

Week 4: Standing, VOR x1 with busy background - challenge visual-vestibular interaction.

Week 5: Standing, VOR x2 horizontal/vertical - advanced gaze stabilization. Week 6: Standing, VOR x2 with busy background - integrate dynamic visual input.

The control group received gaze stabilization exercises for 6 weeks, comprising 18 supervised sessions conducted three times weekly. Training included VOR x1 and VOR x2 exercises in horizontal and vertical planes using near and far visual targets. Exercises progressed from sitting to standing positions and from simple to visually busy backgrounds. Each session also included balance training activities such as weight shifts, tandem stance, pivot turns, and walking with head movements, with rest periods provided as needed.
Aktiv komparator: Optokinetic Training

Purpose:

Reduce visually induced dizziness, enhance balance, and improve confidence in daily activities.

Description:

Week 1: Horizontal stripes Week 2: Vertical motion Week 3: Real-world videos Week 4: Crowded/busy scenes Week 5: Moving environment + light movement Week 6: Provocative videos (spirals/crowded)

The experimental group underwent optokinetic training for 6 weeks with 18 supervised sessions conducted three times weekly. Participants were exposed to progressively challenging moving visual stimuli, including distortion patterns, busy street scenes, motorway driving videos, and chequerboard jiggle/wrap patterns. Training advanced from sitting to standing with dynamic movements as visual complexity increased. Baseline and task-specific balance exercises were incorporated into every session, with adequate rest periods provided when necessary.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Dizziness
Tidsram: 6 weeks

It will be measured by using Dizziness Handicap Inventory.

Score Interpretation:

0-30: Slight or Mild Handicap 31-60: Moderate Handicap 61-100: Severe Handicap

6 weeks
Postural Stability
Tidsram: 6 weeks

It will be measured by using Dynamic Gait Index (DGI).

Interpretation:

≤19 = increased fall risk 20-24 = safe ambulation Higher scores = better gait performance and dynamic balance Lower scores = impaired gait and higher fall risk

6 weeks
Balance Confidence
Tidsram: 6 weeks

It will be measured by using Activities-specific Balance Confidence (ABC) Scale.

Interpretation:

<50% = low level of physical functioning and high fall risk 50-80% = moderate level of functioning80% = high level of functioning and confidence Higher scores = greater balance confidence Lower scores = fear of falling and reduced functional independence

6 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

18 november 2025

Primärt slutförande (Faktisk)

1 maj 2026

Avslutad studie (Faktisk)

1 maj 2026

Studieregistreringsdatum

Först inskickad

7 maj 2026

Först inskickad som uppfyllde QC-kriterierna

7 maj 2026

Första postat (Faktisk)

13 maj 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

7 juli 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

3 juli 2026

Senast verifierad

1 juli 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • FUI/FUCP/CTR/Neuro1/AqsaKhalil

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera